Could Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists Play a Role in Gout Treatment?

Pharmaceutics · 2025 · PMC12300928 · PMID 40733074

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The differences between these studies with regard to ipragliflozin’s uricosuric activity may have resulted from the group comparison in the 12-week study, which did not reach statistical significance vs. intragroup comparison in the ASSIGN-K study.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.